[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ocugen Inc (OCGN)

Ocugen Inc (OCGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 436,693
  • Shares Outstanding, K 338,522
  • Annual Sales, $ 4,410 K
  • Annual Income, $ -67,850 K
  • EBIT $ -66 M
  • EBITDA $ -63 M
  • 60-Month Beta 2.18
  • Price/Sales 99.72
  • Price/Cash Flow N/A
  • Price/Book 77.56

Options Overview Details

View History
  • Implied Volatility 138.51% (+55.73%)
  • Historical Volatility 62.78%
  • IV Percentile 75%
  • IV Rank 15.05%
  • IV High 544.02% on 11/14/25
  • IV Low 66.66% on 07/21/26
  • Expected Move (DTE 29) 0.1445 (11.51%)
  • Put/Call Vol Ratio 0.25
  • Today's Volume 104
  • Volume Avg (30-Day) 1,555
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 61,746
  • Open Int (30-Day) 75,166
  • Expected Range 1.1105 to 1.3995

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.05
  • Number of Estimates 3
  • High Estimate $-0.04
  • Low Estimate $-0.06
  • Prior Year $-0.05
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2400 +1.21%
on 07/23/26
1.6899 -25.74%
on 06/30/26
-0.1250 (-9.06%)
since 06/23/26
3-Month
1.1600 +8.19%
on 06/16/26
1.9000 -33.95%
on 05/04/26
-0.4150 (-24.85%)
since 04/23/26
52-Week
0.9310 +34.80%
on 08/06/25
2.7250 -53.94%
on 03/17/26
+0.0850 (+7.26%)
since 07/23/25

Most Recent Stories

More News
Ocugen, Inc. Announces Binding Term Sheet with Roots Pharmaceutical to License OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in the Middle East and North Africa

Cumulative sales milestones up to $255 million and modest upfront/near-term development milestones Royalties equaling 22% of net sales Ocugen to manufacture and supply OCU400 MALVERN, Pa.,...

OCGN : 1.2600 (-2.33%)
Ocugen to Participate in Upcoming July Industry Conferences

MALVERN, Pa., July 01, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...

OCGN : 1.2600 (-2.33%)
Ocugen to Participate in Upcoming June Investor and Industry Conferences

MALVERN, Pa., June 02, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...

OCGN : 1.2600 (-2.33%)
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes

MALVERN, Pa., May 14, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing...

OCGN : 1.2600 (-2.33%)
Ocugen to Participate in Upcoming May Scientific and Investor Conferences

MALVERN, Pa., May 13, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the...

OCGN : 1.2600 (-2.33%)
Ocugen: Q1 Earnings Snapshot

Ocugen: Q1 Earnings Snapshot

OCGN : 1.2600 (-2.33%)
Ocugen Provides Business Update with First Quarter 2026 Financial Results

Conference Call and Webcast Today at 8:30 a.m. ET Positive 12-month data from the OCU410 Phase 2 ArMaDa clinical trial for geographic atrophy (GA) indicates a statistically significant (p

OCGN : 1.2600 (-2.33%)
Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes

MALVERN, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen”) (NASDAQ: OCGN) today announced the pricing of $115 million aggregate principal amount of 6.75% Convertible Senior Notes due...

OCGN : 1.2600 (-2.33%)
Ocugen's Gene Therapy Timeline Finally Gets a Number Tomorrow

Barchart Research What to Expect from OCGN Earnings OCGN Generated May 4, 2026 Current Price $1.8500 EPS Estimate $$-0.05 Consensus Rating Strong Buy Average Move 6.53% Ocugen's Gene Therapy Timeline Finally...

OCGN : 1.2600 (-2.33%)
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes

MALVERN, Pa., May 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced...

OCGN : 1.2600 (-2.33%)

Business Summary

Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 1.3533
2nd Resistance Point 1.3367
1st Resistance Point 1.3133
Last Price 1.2600
1st Support Level 1.2733
2nd Support Level 1.2567
3rd Support Level 1.2333

See More

52-Week High 2.7250
Fibonacci 61.8% 2.0397
Fibonacci 50% 1.8280
Fibonacci 38.2% 1.6163
Last Price 1.2600
52-Week Low 0.9310

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.